Logo image of CNM

CORE & MAIN INC-CLASS A (CNM) Stock Fundamental Analysis

NYSE:CNM - New York Stock Exchange, Inc. - US21874C1027 - Common Stock - Currency: USD

56.315  -0.55 (-0.96%)

Fundamental Rating

5

CNM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 48 industry peers in the Trading Companies & Distributors industry. While CNM has a great profitability rating, there are some minor concerns on its financial health. While showing a medium growth rate, CNM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CNM had positive earnings in the past year.
In the past year CNM had a positive cash flow from operations.
Each year in the past 5 years CNM has been profitable.
CNM had a positive operating cash flow in 4 of the past 5 years.
CNM Yearly Net Income VS EBIT VS OCF VS FCFCNM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

1.2 Ratios

The Return On Assets of CNM (6.60%) is better than 68.09% of its industry peers.
CNM has a better Return On Equity (24.54%) than 91.49% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.36%, CNM is in the better half of the industry, outperforming 76.60% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CNM is above the industry average of 9.69%.
Industry RankSector Rank
ROA 6.6%
ROE 24.54%
ROIC 11.36%
ROA(3y)6.17%
ROA(5y)4.19%
ROE(3y)19.68%
ROE(5y)14.21%
ROIC(3y)12.93%
ROIC(5y)9.55%
CNM Yearly ROA, ROE, ROICCNM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

CNM's Profit Margin of 5.71% is fine compared to the rest of the industry. CNM outperforms 61.70% of its industry peers.
CNM's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 9.93%, CNM is doing good in the industry, outperforming 63.83% of the companies in the same industry.
CNM's Operating Margin has improved in the last couple of years.
The Gross Margin of CNM (26.63%) is worse than 65.96% of its industry peers.
In the last couple of years the Gross Margin of CNM has grown nicely.
Industry RankSector Rank
OM 9.93%
PM (TTM) 5.71%
GM 26.63%
OM growth 3Y29.72%
OM growth 5Y20.79%
PM growth 3Y65.47%
PM growth 5Y37.09%
GM growth 3Y4%
GM growth 5Y4.17%
CNM Yearly Profit, Operating, Gross MarginsCNM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

CNM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CNM has been reduced compared to 1 year ago.
CNM has a worse debt/assets ratio than last year.
CNM Yearly Shares OutstandingCNM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M 200M
CNM Yearly Total Debt VS Total AssetsCNM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 3.37 indicates that CNM is not in any danger for bankruptcy at the moment.
CNM's Altman-Z score of 3.37 is fine compared to the rest of the industry. CNM outperforms 63.83% of its industry peers.
The Debt to FCF ratio of CNM is 3.70, which is a good value as it means it would take CNM, 3.70 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CNM (3.70) is better than 68.09% of its industry peers.
A Debt/Equity ratio of 1.43 is on the high side and indicates that CNM has dependencies on debt financing.
CNM has a Debt to Equity ratio of 1.43. This is in the lower half of the industry: CNM underperforms 68.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF 3.7
Altman-Z 3.37
ROIC/WACC0.98
WACC11.58%
CNM Yearly LT Debt VS Equity VS FCFCNM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

CNM has a Current Ratio of 2.14. This indicates that CNM is financially healthy and has no problem in meeting its short term obligations.
CNM has a Current ratio of 2.14. This is comparable to the rest of the industry: CNM outperforms 55.32% of its industry peers.
A Quick Ratio of 1.28 indicates that CNM should not have too much problems paying its short term obligations.
CNM has a Quick ratio (1.28) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.28
CNM Yearly Current Assets VS Current LiabilitesCNM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

CNM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.42%.
The Earnings Per Share has been growing by 60.95% on average over the past years. This is a very strong growth
Looking at the last year, CNM shows a quite strong growth in Revenue. The Revenue has grown by 8.24% in the last year.
The Revenue has been growing by 15.92% on average over the past years. This is quite good.
EPS 1Y (TTM)-3.42%
EPS 3Y108.01%
EPS 5Y60.95%
EPS Q2Q%-5.48%
Revenue 1Y (TTM)8.24%
Revenue growth 3Y22.54%
Revenue growth 5Y15.92%
Sales Q2Q%11.55%

3.2 Future

CNM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.59% yearly.
Based on estimates for the next years, CNM will show a small growth in Revenue. The Revenue will grow by 6.73% on average per year.
EPS Next Y-4.22%
EPS Next 2Y1.42%
EPS Next 3Y6.59%
EPS Next 5YN/A
Revenue Next Year10.34%
Revenue Next 2Y7.25%
Revenue Next 3Y6.73%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CNM Yearly Revenue VS EstimatesCNM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
CNM Yearly EPS VS EstimatesCNM Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 24.92, which indicates a rather expensive current valuation of CNM.
The rest of the industry has a similar Price/Earnings ratio as CNM.
CNM is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.64, which is the current average of the S&P500 Index.
CNM is valuated rather expensively with a Price/Forward Earnings ratio of 23.10.
CNM's Price/Forward Earnings is on the same level as the industry average.
CNM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.51.
Industry RankSector Rank
PE 24.92
Fwd PE 23.1
CNM Price Earnings VS Forward Price EarningsCNM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

63.83% of the companies in the same industry are cheaper than CNM, based on the Enterprise Value to EBITDA ratio.
78.72% of the companies in the same industry are more expensive than CNM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.19
EV/EBITDA 15.27
CNM Per share dataCNM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The decent profitability rating of CNM may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.41
EPS Next 2Y1.42%
EPS Next 3Y6.59%

0

5. Dividend

5.1 Amount

CNM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CORE & MAIN INC-CLASS A

NYSE:CNM (1/24/2025, 3:31:58 PM)

56.315

-0.55 (-0.96%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)12-03 2024-12-03/bmo
Earnings (Next)N/A N/A
Inst Owners110.16%
Inst Owner Change-0.12%
Ins Owners0.35%
Ins Owner Change2.32%
Market Cap11.19B
Analysts77.65
Price Target60.97 (8.27%)
Short Float %6.49%
Short Ratio4.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.55%
Min EPS beat(2)-10.01%
Max EPS beat(2)4.9%
EPS beat(4)3
Avg EPS beat(4)0.38%
Min EPS beat(4)-10.01%
Max EPS beat(4)6.32%
EPS beat(8)7
Avg EPS beat(8)3.93%
EPS beat(12)11
Avg EPS beat(12)10.94%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2%
Min Revenue beat(2)-5.49%
Max Revenue beat(2)1.49%
Revenue beat(4)2
Avg Revenue beat(4)-1%
Min Revenue beat(4)-5.49%
Max Revenue beat(4)1.49%
Revenue beat(8)2
Avg Revenue beat(8)-1.35%
Revenue beat(12)6
Avg Revenue beat(12)2.45%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)16.51%
PT rev (3m)17.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.75%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.89%
Revenue NY rev (1m)-0.45%
Revenue NY rev (3m)1.67%
Valuation
Industry RankSector Rank
PE 24.92
Fwd PE 23.1
P/S 1.56
P/FCF 17.19
P/OCF 16.45
P/B 6.7
P/tB N/A
EV/EBITDA 15.27
EPS(TTM)2.26
EY4.01%
EPS(NY)2.44
Fwd EY4.33%
FCF(TTM)3.28
FCFY5.82%
OCF(TTM)3.42
OCFY6.08%
SpS36.16
BVpS8.41
TBVpS-5.92
PEG (NY)N/A
PEG (5Y)0.41
Profitability
Industry RankSector Rank
ROA 6.6%
ROE 24.54%
ROCE 13.98%
ROIC 11.36%
ROICexc 11.38%
ROICexgc 25.83%
OM 9.93%
PM (TTM) 5.71%
GM 26.63%
FCFM 9.06%
ROA(3y)6.17%
ROA(5y)4.19%
ROE(3y)19.68%
ROE(5y)14.21%
ROIC(3y)12.93%
ROIC(5y)9.55%
ROICexc(3y)13.15%
ROICexc(5y)9.86%
ROICexgc(3y)32.43%
ROICexgc(5y)28.05%
ROCE(3y)15.91%
ROCE(5y)11.76%
ROICexcg growth 3Y10.15%
ROICexcg growth 5YN/A
ROICexc growth 3Y41.37%
ROICexc growth 5YN/A
OM growth 3Y29.72%
OM growth 5Y20.79%
PM growth 3Y65.47%
PM growth 5Y37.09%
GM growth 3Y4%
GM growth 5Y4.17%
F-Score3
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF 3.7
Debt/EBITDA 2.66
Cap/Depr 15.76%
Cap/Sales 0.4%
Interest Coverage 4.54
Cash Conversion 75.81%
Profit Quality 158.78%
Current Ratio 2.14
Quick Ratio 1.28
Altman-Z 3.37
F-Score3
WACC11.58%
ROIC/WACC0.98
Cap/Depr(3y)18.52%
Cap/Depr(5y)14.68%
Cap/Sales(3y)0.45%
Cap/Sales(5y)0.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.42%
EPS 3Y108.01%
EPS 5Y60.95%
EPS Q2Q%-5.48%
EPS Next Y-4.22%
EPS Next 2Y1.42%
EPS Next 3Y6.59%
EPS Next 5YN/A
Revenue 1Y (TTM)8.24%
Revenue growth 3Y22.54%
Revenue growth 5Y15.92%
Sales Q2Q%11.55%
Revenue Next Year10.34%
Revenue Next 2Y7.25%
Revenue Next 3Y6.73%
Revenue Next 5YN/A
EBIT growth 1Y-4.93%
EBIT growth 3Y58.95%
EBIT growth 5Y40.02%
EBIT Next Year23.47%
EBIT Next 3Y12.93%
EBIT Next 5YN/A
FCF growth 1Y543.28%
FCF growth 3Y70.48%
FCF growth 5Y63.93%
OCF growth 1Y426.32%
OCF growth 3Y69.43%
OCF growth 5Y60.33%